The incidence and risk factors of dreaming during gastrointestinal endoscopy using propofol

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400093297

Enrollment

Unknown

Registered

2024-12-02

Start date

2024-12-02

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dreaming

Interventions

Observation group:None

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: undergoing painless gastrointestinal endoscopy using propofol Age 18-65 years old; ASA I~II

Exclusion criteria

Exclusion criteria: ASA III-IV; severe cardiac, pulmonary, liver or kidney disease; mental disease, communication disabled or cognitive dysfunction; allergy to propofol or fentanyl; addiction to sedatives or opiods; undergoing anesthesia within 30 days; failure of colonoscopy due to inadequate bowel preparation; refusion to participate.

Design outcomes

Primary

Measure	Time frame
Dreaming ;	—

Countries

China

Contacts

Public ContactZhuonan Sun

Peking University Third Hospital

szn19_lucky5566@163.com+86 187 0105 2470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026